ASK4PHARMA CONSULTING
Board
2 directors, since incorporationDirector
since 03-03-2020
term without a fixed end
listed in the 2025 annual accounts, filed on 28-08-2026
Director
since 03-03-2020
term without a fixed end
listed in the 2025 annual accounts, filed on 28-08-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Artikel 11 - Bevoegdheden van het bestuursorgaan Als er slechts één bestuurder is, is het geheel van de bevoegdheden van de bestuurders aan…”deed of 06-03-2020
Mandates through the years
2 names, the dashed line is todayDirector
Director
Board
Mandates as a list
-
- Director, from 03-03-2020 to date
-
- Director, from 03-03-2020 to date
Control
Founders
,
This company
ASK4PHARMA CONSULTING
Equity €1.5m
Profit €386,067 in 2025
Capital
- Contribution
- €1,000
- Shares
- 1,000
- Contribution per share
- €1
- Equity per share
- €1,494 in 2025
- Source
- deed of 06-03-2020
Articles of association
deed of 06-03-2020 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Saturday of June at 14:00
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Om welke reden en op welk ogenblik ook, een of meerdere vereffenaars aanduiden,bevoegdheden omlijnen en vergoeding bepalen”
Shareholders
At incorporation
deed of 06-03-2020 ↗
- 500 shares (50%) · €500
- 500 shares (50%) · €500